Rare Disease Day and a Focus on Quality

Today is Rare Disease Day. It’s an opportunity to raise awareness of the impact of rare diseases.

Read More

Five for Friday February 23: Celebrating Success in Advancing Medication Use Quality

PQA is working with its members and the broader medication therapy management (MTM) community to build consensus on the research, measurement and strategies needed to evolve our national approach to evaluating MTM service quality.

Read More

New Members Appointed to Serve on Education Advisory Council

As a healthcare quality educator, PQA offers a wide range of learning and education opportunities. The goal of our education programs is to promote the use and impact of PQA measures and advance the quality of medication use through research, strategic partnerships, collaboration and a variety of learning venues.

Read More

PQA’s Commitment to Engaging Individuals and Communities as Partners in Quality

Patients, caregivers, family members and advocates have a critical role to play in high-quality medication use. They provide unique and valuable insights about what is important and meaningful in medication use quality, which supports the development of appropriate and useful quality measures, as well as related education, research and tools that support informed health care decisions and better medication use outcomes.

Read More

PQA Recognizes the Life and Mourns the Passing of Dr. Jeffrey Kelman

PQA mourns the passing of CMS Chief Medical Officer Jeffrey Kelman, MD, MMSc. Kelman served on the PQA Board of Directors for 10 years and most recently served on the board as a CMS Special Advisor. Kelman was a trusted advisor to PQA since its establishment in 2006. He was kind, generous and thoughtful in his support of PQA and its mission.

Kelman joined CMS in 2005 and helped implement the Part D program. He was a passionate advocate for patient-centered care and efforts to improve the quality of medication use. On behalf of our board, members and staff, PQA sends condolences to his family, friends, colleagues and the countless lives he touched during his life and career.

See Dr. Kelman's obituary for more on his life, accomplishments and family.

PCOR Priorities for Addressing SDOH in Pharmacy Settings

PQA and the Patient Advocate Foundation convened a diverse group of patients and pharmacy stakeholders in 2022 to identify and prioritize patient-centered outcomes research (PCOR) topics and evidence needed to improve social determinants of health (SDOH) screening and interventions in the pharmacy setting.

Read More

Five for Friday February 9: Celebrating Success in Advancing Medication Use Quality

Join us as we head back to Baltimore for the 2024 PQA Annual Meeting, May 14-16! Registration is open, so make your plans now to join us and other quality professionals at the premier event for medication use quality.

Read More

Persistence to Basal Insulin Association With Improved Health Outcomes

Insulin persistence is associated with positive health and economic outcomes, according to a study conducted by researchers at the University of Mississippi, the Pharmacy Quality Alliance (PQA), and Ohio Northern University, the results of which were published in Clinical Diabetes in December of 2023. The study highlights the promising applicability of a method to measure insulin persistence at the population level. This same method is the foundation for PQA’s Persistence to Basal Insulin (PST-INS) health plan performance measure.

Read More

Five Actionable Insights for Successful SDOH Initiatives

There is tremendous momentum and a keen focus among PQA member organizations on addressing social determinants and social drivers of health (SDOH). SDOH impacts every aspect of care, including medication use, and the impact of unmet health-related social needs on patient access and use of care, outcomes, total cost of care, well-being and satisfaction is apparent and a priority to payers and providers.

Read More

Five for Friday January 26: Celebrating Success in Advancing Medication Use Quality

PQA has released a third edition of the PQA Social Determinants of Health (SDOH) Resource Guide, which profiles 40 SDOH services, including eight new services and updates to 10 initiatives from the previous two editions.

Read More

Q&A with PQA Chief Operating Officer Melissa Viscovich

PQA’s talented staff is dedicated to improving medication safety, adherence and appropriate use. As experts in measure development, research, education and convening, they lead the implementation of PQA’s quality initiatives to support better medication use and high-quality care. This blog is one in a series profiling PQA's staff.

Read More

Five for Friday January 12: Celebrating Success in Advancing Medication Use Quality

Save the date for the 2024 PQA Annual Meeting, May 14-16, in Baltimore, Md.

Read More

Fourteen Individuals Participate in Inaugural PQA Quality Shadowing Program

To build a larger and more diverse quality workforce, the PQA Quality Shadowing Program provides individuals from diverse groups the opportunity to observe certain nomination-based panels to gain knowledge that can support selection for future panels. 

Read More

PQA’s Top 5 Blogs of 2023

PQA has published more than 80 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2023, here’s a look back at the top five blogs of the year.

Read More

Highlighting the Achievements of 2023

As we near the end of 2023, it’s a great time to reflect on our accomplishments this year. Certainly, each year brings its share of opportunities and challenges, and I’m proud of our progress as an alliance.  

Read More

Elevating Clinical Quality Assurance: The AI Advancement at MedWatchers

This guest blog is one in a series by sponsors of the 2023 PQA Leadership Summit on elevating clinical quality assurance. The views shared in this series are those of the author and do not reflect any PQA positions.

Read More

PQA Appoints New Members to Serve on MUP and QMEP in 2024

PQA has appointed individuals from member organizations to serve on the 2024 PQA Measure Update Panel (MUP) and Quality Metrics Expert Panel (QMEP). 

Read More

Five for Friday December 15: Celebrating Success in Advancing Medication Use Quality

PQA is working with its members and the broader medication therapy management (MTM) community to build consensus on the research, measurement and strategies needed to evolve our national approach to evaluating MTM service quality.

Read More

Public Comment Sought: Draft Call to Action to Advance MTM Quality Measurement

PQA is working with its members and the broader medication therapy management (MTM) community to build consensus on the research, measurement and strategies needed to evolve our national approach to evaluating MTM service quality. 

Read More

Diabetes Medications, Weight Loss Indications, and What It Means for Quality Measurement

Diabetes is a chronic health condition that affects how the body produces or uses insulin, the hormone that regulates blood sugar.1  In the US, 34.2 million adults have diabetes, and 1 in 5 are unaware of their diagnosis.2 Medication is a mainstay in diabetes treatment, and a wide variety of medication classes are used to manage the disease.  

Read More